“Angiotensin converting enzyme inhibitors or angiotensin receptor blockers: evidence for their effects on mortality and major cardiovascular events in hypertensive diabetics”, Rev Port Med Geral Fam, vol. 32, no. 5, pp. 330–38, Sep. 2016, doi: 10.32385/rpmgf.v32i5.11887.